$IBB Headlines 4 reasons the first quarter was better

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 9:45 AM

$IBB Headlines

4 reasons the first quarter was better than it appeared 6:20 a.m. Today - Tim Clift
Biotech starts recovery as ETFs finish day firmly in the black 5:23 p.m. April 16, 2014 - blogs.marketwatch.com
S&P 500 positive for year as stocks rise for 3rd day in row: stock market live blog recap 4:14 p.m. April 16, 2014 - blogs.marketwatch.com
Tech plays try to find a bottom, with key biotech, Internet ETFs all up this week 11:46 a.m. April 16, 2014 - blogs.marketwatch.com
Stocks gain for 2nd day in row after Ukraine fears ease 4:33 p.m. April 15, 2014 - Victor Reklaitis
IShares Nasdaq biotech ETF turns positive, up 1% 3:39 p.m. April 15, 2014 - Russ Britt
Biotech ETFs, shares can't make up their minds on a choppy trading day 2:51 p.m. April 15, 2014 - blogs.marketwatch.com
Stock futures up as Coke, J&J rise after earnings 9:08 a.m. April 15, 2014 - Sara Sjolin
Wash, rinse and repeat the Wall Street spin cycle 5:03 p.m. April 14, 2014 - Dave Fry
Biotech misses out on Nasdaq rally, sinks further into bear ground 4:58 p.m. April 14, 2014 - blogs.marketwatch.com
Dow scores triple-digit gain; Nasdaq jumps back above 4,000: stock market live blog recap 4:06 p.m. April 14, 2014 - blogs.marketwatch.com
Legitimate upturn, or dead-cat bounce? 11:30 a.m. April 14, 2014 - Michael Ashbaugh
Stocks suffer big weekly loss; Nasdaq below 4,000 5:45 p.m. April 11, 2014 - Victor Reklaitis
Carnage continues for biotechs as bears set up camp 5:30 p.m. April 11, 2014 - blogs.marketwatch.com
Stock market live blog: Nasdaq drops to 4,000; stocks lose 1% 4:02 p.m. April 11, 2014 - blogs.marketwatch.com
Biotech stocks flirt with bear territory as shares, ETFs falling down again 10:29 a.m. April 11, 2014 - blogs.marketwatch.com
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
U.S. stock market hit by Nasdaq, biotech rout 4:40 p.m. April 10, 2014 - Anora Mahmudova
This stock market needs a correction 4:04 p.m. April 10, 2014 - Jonathan Burton
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - blogs.marketwatch.com

Expect Biotech Rally To Lead To Further Selling Of Research Stage Companies 8:20 a.m. Today - Seeking Alpha
New clinical trial format may boost cancer drug development 8:04 a.m. Today - Seeking Alpha
The Trader Daily 7:30 a.m. Today - RealMoney.com
Gilead: This Baby Has Been Thrown Away With The Bathwater 8:50 a.m. April 16, 2014 - Seeking Alpha
The Trader Daily 7:30 a.m. April 16, 2014 - RealMoney.com
The Correction As Seen In The ETP Landscape 4:07 p.m. April 15, 2014 - Seeking Alpha
Eight Serious Market Indicators to Watch During This Correction 1:11 p.m. April 15, 2014 - 247WallSt.com
Is Now The Time To Buy Ironwood Pharmaceuticals? 9:15 a.m. April 15, 2014 - Seeking Alpha
The Downside To Chasing Prior Winning Strategies 6:24 p.m. April 14, 2014 - Seeking Alpha
Momentum Stocks Rebound 6:18 p.m. April 14, 2014 - WallStreetSectorSelector
Capitulation Next Week? Or a Bounce to Sell Into Now? 11:37 a.m. April 14, 2014 - TheStreet.com
Has Momentum Investing Lost Its Mojo? 11:28 a.m. April 14, 2014 - Seeking Alpha
Investment Implications Of The Trash Crash: Don't Panic, Don't Kid Yourself, Be Disciplined 10:34 a.m. April 14, 2014 - Seeking Alpha
The Sell-Off In Biotech Is Coming To An End 8:40 a.m. April 14, 2014 - Seeking Alpha
Should You Buy or Sell the Next Bounce? 9:37 p.m. April 13, 2014 - InvestorPlace.com
Is Now The Time To Buy Atrion Corporation? 4:04 p.m. April 13, 2014 - Seeking Alpha
The Market Beyond First Quarter 2014 7:15 a.m. April 13, 2014 - Seeking Alpha
'Fast Money' Recap: The Skid Continues 5:00 a.m. April 12, 2014 - TheStreet.com
Riding the Tech Roller Coaster 7:06 p.m. April 11, 2014 - The Wall Street Journal Interactive Edition
Biotech Rout Not Surprising: Surveying The Damage 4:22 p.m. April 11, 2014 - Seeking Alpha

OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTK, DNDN, IMGN and NVAX 8:43 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FLUX 3 Max Launches with Unmatched Speed and Quality

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

CMS Proposal Sparks Controversy in Lab Certification

A New Contender in the Battle Over Lab Standards Here's what’s heating up in the realm of clinical laboratories: A proposed shift by the Centers for Medicare & Medicaid Services (CMS) that reeks of cutting corners, if you ask the folks at the Association for Diagnostics & Laboratory Medicine (ADLM). They’re banging the drums against CMS's idea to nix the board...

INSPIRE 2026: Luxury Hotel Trends and Investments

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Endava Faces Securities Fraud Lawsuit: Investor Implications

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

PG&E Delivers $26M Climate Credit to Small Biz

California's Big Move for Small Businesses In a world where every dollar counts, small businesses across Northern and Central California are getting a helping hand. Pacific Gas and Electric Company (PG&E) is stepping up with a tidy little climate credit thanks to the state's Cap-and-Invest Program. Eligible businesses are automatically set to receive a $36.18 credit off...

Brown Plus Ranks #8 Best Workplace for Women 2026

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Kenneth Smith Takes Helm for Trends Int’l Expansion

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

JELD-WEN CFO Transition: Navigating Finances Amid Changes

Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...

Hyliion Legal Woes Shake Investor Confidence

Legal Storm Brews Over Hyliion Investments If you think riding the stock market is like sailing a calm sea, wake up. Hyliion Holdings Corp. (NYSE:HYLN) finds itself steaming headlong into rough waters. A securities class action lawsuit, Olmeta v. Hyliion Holdings Corp., accuses the company of embellishing its ambitions. The lawsuit cites potential wrongdoing in a...

Flotek Faces Class Action as PREPA Contract Dissolves

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...